| Ellerton, John A |
Southern Nevada Cancer Research Fdn
United States |
NCI Community Oncology Research Program (NCORP) Community Sites (UG1 Clinical Trial Required) |
5UG1CA189829-10 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
| Enzinger, Andrea C |
Dana-Farber Cancer Inst
United States |
Development of A Mindfulness-Based Mobile Health Intervention for Patients Coping with Pain from Advanced Malignancies |
5R21CA270069-02 |
|
|
| Esserman, Laura J |
University Of California, San Francisco
United States |
Extending the Diversity, Reach, and Generalizability of the WISDOM Study |
5R01CA237533-05 |
|
|
| Fabian, Carol J |
University Of Kansas Medical Center
United States |
Biomarker-Based Phase IIB Trial of (Bazedoxifene-Conjugated Estrogen) to Reduce Risk for Breast Cancer |
5R01CA249437-03 |
|
Edward Sauter, M.D., Ph.D. |
| Fahrmann, Johannes F |
University Of Tx Md Anderson Can Ctr
United States |
Blood-Based Biomarkers for Personalized Risk Assessment of Breast and Ovarian Cancer |
1U01CA282216-01 |
|
Claire Zhu, Ph.D. |
| Faller, Bryan |
Decatur Memorial Hospital
United States |
Heartland Cancer Research NCORP |
5UG1CA189830-10 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
| Fan, Rong |
Yale University
United States |
Immuno-Serological Assays for Monitoring COVID19 in Patients with Hematologic Malignancies |
3U01CA260507-02S2 |
|
|
| Faris, Gregory W |
Numentus Technologies Inc.
United States |
Decoding Individual Exosomes in Cancer |
5R21CA236686-02 |
|
|
| Feliciano, Elizabeth Marjorie Cespedes |
Kaiser Foundation Research Institute
United States |
D3-creatine dilution to determine skeletal muscle mass in colon cancer patients |
5R01CA240394-04 |
PAR-18-893 (R01 Clinical Trial Optional) |
Gabriela Riscuta, M.D., C.N.S. |
| Feng, Ziding |
Fred Hutchinson Cancer Center
United States |
Consortium on Translational Research in Early Detection of Liver Cancer:Data Management and Coordinating Center (DMCC) |
2U24CA230144-07 |
|
Guillermo Marquez, Ph.D. |